Quintara Discovery Competitors and Similar CompaniesClear all
Quintara Discovery's competitors and similar companies include Paraza Pharma, Cipla, Biogen and Cadila Pharmaceuticals.
 Quintara Discovery Quintara Discovery, Inc. (QDI) is a company that specializes in drug discovery and development. |  Paraza Pharma Paraza Pharma is a contract research organization specializing in end-to-end drug discovery and development services for the pharmaceutical and biotech industries. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | |
Founding Date | Founding Date 2012 | Founding Date 2011 | Founding Date 1935 | Founding Date 1978 | Founding Date 1951 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | Tags Healthcare | ||||
Locations | Locations Hayward, US HQ | Locations Montréal, CA HQ Laval, CA Montréal, CA Cambridge, US | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees 620% increase | Employees 246 | Employees 27,764 | Employees 7,605 | Employees 8,5201% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹195b (FY, 2026) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income $1.3b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Paraza Pharma
HQ
Montréal, CA
Employees
246
Paraza Pharma is a contract research organization specializing in end-to-end drug discovery and development services for the pharmaceutical and biotech industries.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company